Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
A new study demonstrates that the history and physical exam provides important prognostic information in patients with HFpEF, as it does in those with HFrEF--but there are important differences.
The presence of unexpectedly low natriuretic peptide concentrations in patients with heart failure may be indicative of natriuretic peptide deficiency. What are the implications?
Tafamidis, a daily, orally available medication, has proven highly effective in the treatment of transthyretin amyloid cardiomyopathy, but its high cost puts it out of reach of most patients.
This paper summarizes the discussions and expert consensus recommendations made by a multi-stakeholder group in regards to building an implementation science framework across HFrEF care.
Mission Statement:
Aligned with the ACC's mission to transform cardiovascular care and improve heart health, the JACC Journals continuously strive to provide the best resources for cardiovascular investigators, clinicians, and specialists at every professional stage.
